Contact

UK Office

Only Medics
Second Floor
7 - 11 Station Road
Reading, Berkshire
RG1 1LG, UK

Tel -
+44(0)1189 522799

Email -
info@onlymedics.com

EU Office

Only Medics
Quantum House
22 - 24 Red Lion Court
Fleet Street, London
EC4A 3EB, UK

Tel -
+44(0)2078 221719

Share &
Connect

Keep connected & join the Only Medics Network here.

LinkedIn Facebook Twitter

Specialist Sectors

  • Campaigners Target Andrew Lansley at NICE Conference

    May 16, 2012 Unrest over the government’s health bill came to the fore again at this week’s NICE conference, with one protestor questioning the UK Health Secretary over his rejection to issue the NHS risk register during his speech to delegates yesterday. This is the second time that the Health Secr...

  • Merck KGaA Targets 300 Million Euros Cost Savings as Profits Fall

    May 14, 2012 Merck KGaA has revealed information regarding their new restructuring strategy and is targeting cost savings of 300 million euros at their drugs unit by 2014. Karl-Ludwig Kley, Chairman of the German organisation, noted that they face “unprecedented market shifts and increasing competition in...

  • NHS Could Save £350 Million Yearly From Generic Lipitor

    May 10, 2012 The admittance of generic forms of Pfizer's cholesterol lowering drug, Lipitor (atorvastatin), onto the UK market could in time save the NHS £350 million annually. According to the Generic Manufacturers' Association, the loss of Lipitor's patent protection in the UK and the accessibility of l...

  • UK Researchers Halt Brain Cell Death in Mice

    May 08, 2012 UK researchers have exposed the basis of what could become a new method to treat degenerative brain illnesses such as Alzheimer's and Parkinson's. Scientists from the University of Leicester have, by tackling a new pathway, managed to stop brain cell death in mice with prion disease, a progressive ...

  • MHRA Reveals New Strategy to Crack Down on Fake Drugs

    May 02, 2012 The MHRA (Medicines and Healthcare products Regulatory Agency), a government agency responsible for ensuring that medicines and medical devices work and are acceptably safe, has revealed their new anti-counterfeiting policy to increase the clamp down on fake drugs arriving in the UK supply chain. D...

  • Watson Pharmaceuticals Announces Strong First Quarter

    Apr 30, 2012 Watson Pharmaceuticals, which are currently in the procedure of acquiring generics firm Actavis for 4.25 billion euros, announced strong earnings and revenue increases for their first quarter on Monday. The company’s net income was up by 22% from $45.3 million to $54.8 million, while revenues...

  • Strong Vyvanse Sales Boost Shire’s First Quarter

    Apr 26, 2012 Shire posted another strong set of results yesterday, with a 20 percent rise in first-quarter earnings, just beating market expectations, and their attention-deficit hyperactivity disorder (ADHD) treatments and rare disease drugs once again performing well. Shire, whose development has outstripped ...

  • GlaxoSmithKline Announce Q1 Results

    Apr 24, 2012 Pharmaceutical drug maker, GlaxoSmithKline (GSK), today announced that their revenue increased just 1% in the first quarter, reflecting burdens on the organisation from government price cuts in Europe and some emerging markets, and hard year-by-year comparisons. GSK’s results were boosted by ...

  • The Department of Health Moves to Secure Quicker Access to Cancer Drugs Fund

    Apr 23, 2012 The Department of Health has issued new guidance on the Cancer Drugs Fund which, it says, should help National Health Service patients in England gain much faster access to innovative medicines. Launching the new guidance earlier this week, Health Minister Lord Howe commented that applications to t...

  • GlaxoSmithKline Retains Friendly Approach, Despite Hostile HGS Bid

    Apr 19, 2012 In confirming its unsolicited $2.60 billion offer for Human Genome Sciences (HGS), which was rejected, GlaxoSmithKline (GSK) commented that they still hope to push through the bid “on a friendly basis.” The UK drugs manufacturer noted that the $13.00 per share offer represented an 81% p...

  • Johnson & Johnson Profits Increase

    Apr 17, 2012 Johnson & Johnson (J&J) yesterday reported a 12.5% growth in earnings for their first quarter, assisted by sales of new products, the most noticeable being the prostate cancer drug Zytiga. The group’s net earnings came in at $3.91 billion, while turnover fell 0.2% to $16.14 billion.&n...

  • Only Medics’ Mobile Website Is Now Live

    Apr 15, 2012 To further enhance our services we today have launched our new mobile website, offering candidates an easier alternative when searching for their next pharmaceutical physician vacancy using their mobile. With an increasing number of people accessing the internet via their mobiles, Only Medics, as t...

  • Study Shows Huntington's Reduces Cancer Risk

    Apr 11, 2012 According to a study in Sweden, people who have developed Huntington's disease, a debilitating brain condition, appear have a "protection" from cancer. The findings, which were published in The Lancet Oncology, analysed almost 40 years of medical records, showing that patients with Huntington&rsquo...

  • Lansley Urges NHS Groups To Use New Power And Freedom To Innovate

    Apr 09, 2012 Over half of future NHS commissioning funds have already been delegated to clinical commissioning groups (CCGs), "and the number is rising all the time," Health Secretary Andrew Lansley has told CCG clinical and managerial leads. Mr Lansley wrote to Clinical Commissioning Groups highlighting the fr...

  • Eisai Joins Up With Valeant To Promote Halaven

    Apr 03, 2012 After failing to gain approval from UK cost watchdog, NICE, for the use of Halaven in treating breast cancer, Eisai has linked up with Valeant Pharmaceuticals International, to promote the drug in Central and Eastern Europe. Halaven received European Commission approval in March 2011. Valeant's Ph...

  • Court of Justice Finds Poland's Low-cost Treatment Law Breaks EU Rules

    Apr 01, 2012 The EU Court of Justice ruled on Thursday last week that a Polish law which allows the sale of prescription medicine that has not been permitted by the European Medicines Agency (EMA) but is similar and cheaper to drugs which have, breaches European Union (EU) law. Under European law, no prescripti...

  • Boehringer Ingelheim Reduces Cost of Pradaxa by 13%

    Mar 28, 2012 Boehringer Ingelheim has announced that they will be decreasing the price of their oral anticoagulant Pradaxa (dabigatran etexilate) by 13% to £2.20 per day, from 1st April 2012. The change comes two weeks after the National Institute for Health and Clinical Excellence (NICE) issued a final g...

  • UK Government Increases Funding For Dementia Research

    Mar 26, 2012 The UK government has pledged to more than double annual funding for research into dementia and neurodegenerative diseases to over £66 million by 2014/15, in an increase from £26.6 million in 2009/10. The commitment was announced yesterday by the UK Prime Minister, David Cameron, as par...

  • Lung Cancer Detection Trial Announced For Smokers

    Mar 23, 2012 A simple blood test which can identify lung cancer five years before conventional screenings will be trialled by the NHS on 10,000 high risk smokers. The trial is being tested in Scotland in the anticipation that it could provide the first national screening programme for lung cancer in addition to...

  • UK MPs Approve Controversial NHS Bill

    Mar 21, 2012 The NHS health bill has survived the final parliamentary test and is set to become law. Labour’s call for MPs to delay their final consideration of the NHS overhaul in England until an evaluation of the potential risks is available was defeated by 82 votes. An emergency debate over the propo...

  • Medicine Access Changes Will Help Companies Develop, UK MPs Told

    Mar 15, 2012 UK MPs have been told that regulatory proposals currently being considered for quicker entrance for medicines which meet key unmet medical needs provide an opportunity for small life science businesses to grow to middle-sized organisations. In December 2011, the UK’s Prime Minister, David Cam...

  • Pharmaceutical Industry is 'Safe Haven' for Investors

    Mar 13, 2012 Analysts at Peel Hunt have analysed the global healthcare sector, and stated that it is in a fairly healthy condition, in spite of the pressures the industry is currently under. Contained within the report, the broker claims that the healthcare sector "has again proved its resilience in periods of ...

  • Pharmaceutical Industry Should Invest Further in Anti-Obesity Drugs

    Mar 09, 2012 Pharmaceutical organisations should increase their investment in anti-obesity drugs to respond to the rising number of clinically obese people globally. This is the main message from a report by business intelligence specialist, GlobalData, which observes that the obesity market is lucrative, large...

  • ICON’s MIRA Chosen by Roche for Medical Image Repository

    Mar 07, 2012 Continuing its move from transactional relationships to strategic alliances with clients, ICON have announced that they have been chosen by Roche as Roche’s technology partner for storing and managing medical images collected during clinical research programmes. ICON is an international suppl...

  • Only Medics To Attend DGPharMed 2012

    Mar 05, 2012 Only Medics will be attending DGPharMed’s annual conference at the Hotel Pullman Cologne, in Germany on the 8th and 9th March 2012.2012 sees the 28th year of the annual conference by the German Society of Pharmaceutical Medicine.The conference starts at 9:20am on Thursday 8th March, and finish...

  • UK’s NICE Dismisses Drug Delay Statements

    Mar 01, 2012 The UK’s National Institute for Health and Clinical Excellence (NICE) has not been requested to alter the basis of their assessments "simply to save money," NICE’s chief executive, Sir Andrew Dillon, has stated. Sir Andrew Dillon was replying to media reports from earlier this week, whi...

  • Only Medics at the 2012 BrAPP Annual Symposium

    Feb 28, 2012 Only Medics will be attending this year’s BrAPP Conference on 1st March 2012 in London.2012 sees BrAPP celebrating its 55th year as the professional association for pharmaceutical physicians.The conference starts at 9am, and is followed by a three course dinner with guest speaker, Professor Tr...

  • Study Finds Selected Dementia Antipsychotics Raise Death Risks

    Feb 24, 2012 Nursing home residents over 65 who take certain antipsychotics for dementia are at an increased risk of death, according to a recent study by the Harvard Medical School involving 75,445 patients. In a paper published on bmj.com, the study, which was the largest ever undertaken among US nursing home...

  • Berkeley Lab Discover New Evidence On How ‘Good’ Cholesterol Turns ‘Bad’

    Feb 22, 2012 Researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have discovered new proof to clarify how cholesteryl ester transfer protein (CETP) mediates the move of cholesterol from "good" high density lipoproteins (HDLs) to "bad" low density lipoproteins (LD...

  • Health Inequalities Increase, As Experts Warn Over Health Plans

    Feb 16, 2012 Two years after the Marmot Review Fair Society, Healthy Lives was released, new data revealed yesterday illustrates that health inequality between the poor and the rich are continuing to grow, although there has been an improvement in average life expectancy.According to figures from the Institute o...

  • US green light for Merck & Co's eye drug Zioptan

    Feb 14, 2012   The US Food and Drug Administration has given the nod to Merck & Co's eye solution Zioptan for lowering intraocular pressure in patients with certain eye conditions. Shares in the drugmaker were given a bump after it announced that Zioptan (tafluprost ophthalmic solution) 0.0015%...

  • Eisai Receives Positive Alzheimer Study Results, While FDA Rejects Dacogen

    Feb 10, 2012 Eisai has received mixed news this week, after news that Dacogen, Eisai and Astex Pharmaceuticals’ drug to treat a type of leukaemia, has been rejected by an independent advisory panel to the regulator in the USA.The US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Commit...

  • Osteoporosis Market Predicted To Grow To $11.4B By 2015

    Feb 08, 2012 The global market for osteoporosis drugs is expected to increase from $7.3 billion in 2010 to $11.4 billion by 2015, according to new estimates. The market will achieve an average annual growth of 9.2% during this period, according to the report published by Transparency Market Research. The stud...

  • Competition Could Benefit the NHS, Declares the Office of Health Economics

    Feb 02, 2012   Competition can help the integration of care in the NHS, and there is no proof that it would hinder it, according to a new report from the Office of Health Economics. The report analyses the conclusions of the Commission on Competition in the NHS, which was assembled by the OHE (Office of...

  • New Children's Health Outcomes Strategy Planned By UK Government

    Jan 31, 2012 The UK government has revealed new plans for a focus to improve health care for children and young people.The ‘Children's and Young People's Outcomes Strategy’, which will be unveiled later in the year, will concentrate on improving healthcare service outcomes for children, including tho...

  • Our Latest Advert in BrAPP January 2012

    Jan 26, 2012 Our newest advert has been published in the latest issue of BrAPP's Pharmaceutical Physician Magazine. It can be downloaded in our Brochure and latest adverts section. Tell us what you think!...

  • Frost & Sullivan Study Finds Major Development Potential for European CMOs

    Jan 25, 2012 The European pharmaceutical contract manufacturing market made revenues of $10.02 billion in 2011, and this figure is expected to double to $20.75 billion by 2018, according to new forecasts.Over the same time period, the European market for biotechnology contract manufacturing is expected to increa...

  • BAPW Appeal for Objective Monitoring of Branded Medicine Supplies

    Jan 19, 2012 The BAPW (British Association of Pharmaceutical Wholesalers) has appealed for pharmacies and manufacturers to support third-party monitoring and reporting of branded drug supplies.Critical deliberation should be given to the establishment of a robust, objective monitoring and survey service of medic...

  • Hospital Patient Service Cuts Are Hard To Defend, Says Nuffield Trust Report

    Jan 17, 2012 Cuts in patient services are difficult to rationalise when there are many ways hospitals could improve their efficiency, a major new evaluation prepared for the Nuffield Trust by Jeremy Hurst and Sally Williams has concluded.While inefficiencies in areas such as rates of day case surgery, length of ...

  • Investigative Sites Continued to Shrink Over Last Five Years

    Jan 11, 2012 The international landscape for investigative sites, research centres that conduct clinical research, has continued to decline over the past five years, according to US-based information services provider CenterWatch.The global economic downturn is combining with decreasing study numbers, budget pre...

  • European GPs Are Concerned That Health Systems Will Fail As Population Ages

    Jan 05, 2012 Roughly 80% of doctors are concerned about how they will be treated when they grow old and fear that present guidelines to deal with the ageing population are not "comprehensive, realistic or sufficiently funded to address future demand".That is one of the main findings of a recent study from the Ec...

  • "Choose your GP" Pilots Announced for April

    Jan 03, 2012 UK Health Secretary, Andrew Lansley, has announced that one-year pilot schemes for a new initiative which allow patients to choose their GP practice will start in April this year. The trials, which will run in parts of central London, Manchester/Salford and Nottingham, will allow the public, for ...

  • European Proposals Would "Give More Scope for Negotiation" says the NHS

    Dec 22, 2011 The EU’s (European Union) proposal for a new directive on public procurement will permit "more scope for negotiating with suppliers," according to the NHS Confederation. The plans, which have been published by the European Commission this week, contain a number of provisions intended to sim...

  • Multiple Myeloma Therapy Market Set For "Robust" Annual Growth

    Dec 21, 2011 The multiple myeloma drug therapy market will experience robust growth averaging 5.6% annually from 2010 to 2020 in seven of the world’s major markets, according to new projections. Growth in these markets - US, Italy, Spain, UK, France, Germany and Japan - will be driven by additional pene...

  • Merry Christmas, from the Only Medics Team

    Dec 20, 2011 We would like to wish all of Only Medics' clients and candidates a very Merry Christmas and Best Wishes for the New Year. Thank you for your business in 2011 and we look forward to working with you in 2012!Please note the following office hours:Only Medics will be closed from midday on Friday, 23r...

  • NHS To Receive £2.5 Billion Funding Boost for 2012-2013

    Dec 20, 2011 The NHS is to gain a funding boost of over £2.5 billion to deliver services to patients in 2012-13, Health Secretary Andrew Lansley has announced. £91.6 billion will be given to Primary Care Trusts, representing a 2.8% rise in total allocations.  The funding breaks down as follow...

  • Galapagos Reaches Milestone in Servier Osteoarthritis Agreement

    Dec 16, 2011 Galapagos of Belgium yesterday announced that they have reached milestones in its osteoarthritis alliance with Servier, resulting in a payment of 4 million euros from the French drugmaker.In July 2010, teamed up for a collaboration that could be worth around 300 million euros to the Mechelen-based g...

  • Challenging 2012 Predicted for the Pharmaceutical Industry

    Dec 15, 2011 Ratings agency Fitch has issued a report predicting that the pharmaceutical sector will "continue to experience significant operating challenges" in 2012 but while issuing a negative outlook, they added that pharmaceuticals will still be one of the highest-rated industries. The new analysis comme...

  • UK Audit Finds That Lung Cancer Care is Improving Every Year

    Dec 13, 2011 The National Lung Cancer Audit announced that the proportion of patients receiving key care measures, such as surgery or anti-cancer treatment like chemotherapy or radiotherapy, is improving each year.58.4% of patients with lung cancer in England and Wales and 63.9% in Scotland received an anti-canc...

  • Haemophilia B Gene Therapy Injection Shows Initial Success

    Dec 12, 2011 A small trial which shows that symptoms improved considerably in adults with the bleeding disorder haemophilia B, after a single treatment with gene therapy, has caused excitement among the scientific community.A single treatment with gene therapy developed by researchers at St Jude Children's Resea...

  • Only Medics' Sister Company, Clinical Professionals, Achieves Sunday Times Fast Track 100 Top 50 Ranking

    Dec 12, 2011 Fast Track, in association with the Sunday Times, has this week revealed Britain’s fastest growing private firms. Only Medics' sister company, Clinical Professionals, was ranked in the Top 50 within The Sunday Times Virgin Fast Track 100 league table for 2011.The league table ranks Britain&rsq...

  • Johnson & Johnson To Pay Nearly $1 Billion for Pharmacyclics' Cancer Drug

    Dec 09, 2011 Johnson & Johnson have entered into an agreement to help develop a cancer compound discovered by Pharmacyclics in a deal that could be worth close to $1 billion to Pharmacyclics.Johnson & Johnson's Janssen Biotech subsidiary will work together to develop and market the drug, known as PCI-327...

  • Roche Set Up Swiss Academic Translational Centre

    Dec 08, 2011 Roche yesterday announced that they are increasing their collaborative efforts with academic researchers to deliver the next generation of targeted therapies for unmet medical needs by creating an external academic translational research hub in their home market. The hub in Zurich, Switze...

  • Lifestyle Choices Cause More Than 100,000 Cancers Each Year

    Dec 07, 2011 A report by Cancer Research has revealed that 40% (100,000) of cancers diagnosed annually in the UK are caused by a person's lifestyle choice and could potentially have been prevented.  The main causes of the cancers included smoking, eating the wrong type of daily diet, and drinking alcohol.Th...

  • Pharmaceutical Industry Receives Boost from UK Government Plans to Improve Medicine Access

    Dec 06, 2011 Earlier access to new medicines and automatic inclusion of NICE-recommended treatments onto local formularies are some of the many measures included in a package announced yesterday by the UK Prime Minister, David Cameron, as part of the UK's Life Sciences Strategy and the NHS Chief Executive, Sir D...

  • Eli Lilly Conduct Study into the Barriers of Progression in Insulin Treatment

    Dec 02, 2011 Eli Lilly and Company yesterday announced that they are conducting the first major international, prospective observational study intended to understand the real-world difficulties that people with type 2 diabetes face that result in preventing them from attainment their ultimate treatment goals. ...

  • NHS Urge Improved Joint Working with Pharma

    Dec 01, 2011 Joint working with pharmaceutical companies should be "explicitly" positioned as an enabler of clinical commissioning, according to the NHS. The ethos and local emphasis of the NHS / industry joint working initiatives are closely aligned with the values of clinical commissioning, and their foc...

  • Pharmaceutical Google+ Pages

    Nov 21, 2011 As Google+ becomes a more integrated part of our on-line searches, we thought we would list here the major Pharmaceutical companies with a dedicated page up on the network. Adding them to your circles will allow you to follow their latest research updates as well as any developments the pharmace...

  • Only Medics now on Google+

    Nov 09, 2011 Only Medics have recently created a dedicated page on Google+ Add us to your circles to be kept up to date on the latest careers and industry news for pharmaceutical physicians. Only Medics are the forefront of their field, of which we hope this we become another useful networking and informatio...

  • New Only Medics Article - The Interim

    Nov 07, 2011 Following on from our successful line of articles, a pharmaceutical physician from the industry has written an article for us on the subject of Interims. A very insightful read for those looking to move their career in this direction or wishing to know more information on the topic. Just head to...

  • Latest BrAPP Advert now Published (September 2011)

    Sep 11, 2011 Following on from our new set of advert designs, our new BrAPP advert is now live. Read the latest issue of Pharmaceutical Physician to see it in print, or download it from the 'Brochure and Latest adverts' Section of the website....

  • Social Media Focus

    Jul 25, 2011 Only Medics continues to see an increase in group numbers for our social media groups. We now have a number of groups on LinkedIn and a Twitter group to assist candidates looking for employment. After becoming one of the first pharmaceutical recruitment companies to network using LinkedIn grou...

  • Only Medics in the National Online Recruitment Awards 2011

    Jun 23, 2011 Only Medics have recently been entered in for the National Online Recruitment Awards, NORA. Established in 2001, NORA reward the excellence in the UK online recruitment process, that has been unparalleled anywhere else in the world. We are delighted to be a part of these prestigious awards,...

  • New Website now Live.

    Jun 01, 2011 After Months of Planning and feedback from Only Medics and our clients and contacts we are proud to present our new website. We feel it is a vast improvement on the old structure, and allows for much easier navigation and focus on the areas important to yourselves. We hope we continue to be a us...

  • Latest BrAPP Advert now Published (May 2011)

    May 18, 2011 Our latest BrAPP advert is was very warmly received in the latest issue of Pharmaceutical Physician. It is now also available as a PDF download in our Brochure and Adverts section....

  • Latest BrAPP Advert now Published (March 2011)

    Feb 09, 2011 Our latest advert to be published in the BrAPP pharmaceutical Physician Magazine is now available in the Brochure and Adverts section of the website....

Job Search

Advanced job search

Register your C.V.

News

Testimonials